MetaADEDB 2.0 @ LMMD
Tamsulosin
(DRHKJLXJIQTDTD-OAHLLOKOSA-N)
Structure
SMILES
CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C
Type(s)
Approved; Investigational
ATC code(s)
G04CA02; G04CA52; G04CA53
Molecular Formula:
C20H28N2O5S
Molecular Weight:
408.512
Log P:
4.5129
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
108.26
CAS Number(s):
106133-20-4
Synonym(s)
1.
Tamsulosin
2.
5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
3.
Flomax
4.
LY 253352
5.
LY-253352
6.
Tamsulosin Hydrochloride
7.
YM 617
8.
YM-617
External Link(s)
MeSHD000077409
PubChem Compound129211
BindingDB50060964
ChEBI9398
CHEMBLCHEMBL836
DrugBankDB00706
DrugCentral2562
IUPHAR/BPS Guide to PHARMACOLOGY488
KEGGcpd:C07124
dr:D08560
Therapeutic Target DatabaseD05MBZ
ZINC1530694
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 63
Canada Vigilance: 13
10676828
19837435
CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
2SyncopeFAERS: 51
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
3Drug ineffectiveFAERS: 49
Canada Vigilance: 42
Canada Vigilance
US FAERS
4Urinary RetentionFAERS: 32
Canada Vigilance: 4
10676828CTD
Canada Vigilance
US FAERS
5Visual ImpairmentFAERS: 25SIDER
US FAERS
6Product substitution issueFAERS: 24
Canada Vigilance: 40
Canada Vigilance
US FAERS
7Macular fibrosisFAERS: 20US FAERS
8CataractFAERS: 19SIDER
US FAERS
9NauseaFAERS: 19
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
10AstheniaFAERS: 17
Canada Vigilance: 1
10676828CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
11Eye painFAERS: 17US FAERS
12HeadacheFAERS: 17
Canada Vigilance: 2
10676828CTD
SIDER
Canada Vigilance
US FAERS
13MalaiseFAERS: 15
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
14DysuriaFAERS: 14
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
15HypotensionFAERS: 14SIDER
US FAERS
16Atrial FlutterFAERS: 13US FAERS
17Floppy iris syndromeFAERS: 12
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
18MyalgiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
19Product quality issueFAERS: 11US FAERS
20Abdominal PainFAERS: 10
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
21TachycardiaFAERS: 10SIDER
US FAERS
22VomitingFAERS: 10
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
23ArthralgiaFAERS: 9SIDER
US FAERS
24Medication ErrorFAERS: 9US FAERS
25PruritusFAERS: 9
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
26UrticariaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
27Cataract operation complicationFAERS: 8US FAERS
28Depressed moodFAERS: 8US FAERS
29Drug prescribing errorFAERS: 8US FAERS
30Product use issueFAERS: 8US FAERS
31Pulmonary EmbolismFAERS: 8US FAERS
32AmnesiaFAERS: 7US FAERS
33Choroidal DetachmentFAERS: 7US FAERS
34DacryocystitisFAERS: 7US FAERS
35Dacryostenosis acquiredFAERS: 7US FAERS
36DiplopiaFAERS: 7US FAERS
37DyspepsiaFAERS: 7OFFSIDES
SIDER
US FAERS
38Eye BurnsFAERS: 7US FAERS
39Gamma-Glutamyltransferase IncreasedFAERS: 7US FAERS
40GoutFAERS: 7US FAERS
41Lip swellingFAERS: 7US FAERS
42PalpitationsFAERS: 7
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
43Peripheral swellingFAERS: 7US FAERS
44Retinal Vein OcclusionFAERS: 7US FAERS
45Retrograde ejaculationFAERS: 7SIDER
US FAERS
46Urinary tract infectionFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
47Angle Closure GlaucomaFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
48BradycardiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
49ConstipationFAERS: 6
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
50DisorientationFAERS: 6US FAERS
51Erectile dysfunctionFAERS: 616526818CTD
OFFSIDES
SIDER
US FAERS
52Hallucinations, mixedFAERS: 6US FAERS
53Product formulation issueFAERS: 6US FAERS
54Product use in unapproved indicationFAERS: 6US FAERS
55Urinary IncontinenceFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
56UveitisFAERS: 6US FAERS
57Abdominal discomfortFAERS: 5
Canada Vigilance: 9
Canada Vigilance
US FAERS
58ConjunctivitisFAERS: 5US FAERS
59Drug withdrawal syndromeFAERS: 5US FAERS
60HypersensitivityFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
61Hypotonic urinary bladderFAERS: 5US FAERS
62OverdoseFAERS: 5US FAERS
63PresyncopeFAERS: 5US FAERS
64Product physical issueFAERS: 5US FAERS
65Pupillary blockFAERS: 5US FAERS
66AgeusiaFAERS: 4US FAERS
67AngioedemaFAERS: 4OFFSIDES
SIDER
US FAERS
68AnxietyFAERS: 4OFFSIDES
US FAERS
69Benign Prostatic HyperplasiaFAERS: 4OFFSIDES
US FAERS
70Blood glucose increasedFAERS: 4US FAERS
71Drug ineffective for unapproved indicationFAERS: 4US FAERS
72ErythropeniaFAERS: 4US FAERS
73FolliculitisFAERS: 4OFFSIDES
US FAERS
74HypophagiaFAERS: 4US FAERS
75Night sweatsFAERS: 4US FAERS
76PriapismFAERS: 4SIDER
US FAERS
77PsoriasisFAERS: 4US FAERS
78Respiratory distressFAERS: 4US FAERS
79RhinitisFAERS: 4OFFSIDES
SIDER
US FAERS
80ThrombocytopeniaFAERS: 4US FAERS
81Vitreous lossFAERS: 4US FAERS
82Chest PainFAERS: 3SIDER
US FAERS
83Circumstance or information capable of leading to medication errorFAERS: 3US FAERS
84DysphoniaFAERS: 3US FAERS
85ErythemaFAERS: 3US FAERS
86Iatrogenic injuryFAERS: 3US FAERS
87Male Orgasmic DisorderFAERS: 3US FAERS
88Megakaryocytes increasedFAERS: 3US FAERS
89Middle insomniaFAERS: 3OFFSIDES
US FAERS
90MyoglobinuriaFAERS: 3US FAERS
91NocturiaFAERS: 3
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
92Occupational exposure to productFAERS: 3US FAERS
93Painful ejaculationFAERS: 3US FAERS
94Rash erythematousFAERS: 3US FAERS
95Therapeutic response unexpectedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Throat irritationFAERS: 3US FAERS
97Urinary hesitationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Weight decreasedFAERS: 3US FAERS
99Atrial FibrillationFAERS: 2SIDER
US FAERS
100Back PainFAERS: 2SIDER
US FAERS
101Blood urine presentFAERS: 2OFFSIDES
US FAERS
102Cerebral InfarctionFAERS: 2US FAERS
103Disease recurrenceFAERS: 2US FAERS
104Drug ToleranceFAERS: 2US FAERS
105Eyelid rashFAERS: 2US FAERS
106FatigueFAERS: 2OFFSIDES
SIDER
US FAERS
107GlaucomaFAERS: 2US FAERS
108Hormone level abnormalFAERS: 2US FAERS
109IncontinenceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
110Intentional product misuseFAERS: 2US FAERS
111LacerationFAERS: 2US FAERS
112Memory impairmentFAERS: 2US FAERS
113Musculoskeletal chest painFAERS: 2US FAERS
114Musculoskeletal stiffnessFAERS: 2OFFSIDES
US FAERS
115Myocardial InfarctionFAERS: 2US FAERS
116NervousnessFAERS: 2US FAERS
117Oropharyngeal painFAERS: 2US FAERS
118PapuleFAERS: 2US FAERS
119PhlebitisFAERS: 2US FAERS
120PhotophobiaFAERS: 2US FAERS
121Premature EjaculationFAERS: 2US FAERS
122Product comminglingFAERS: 2US FAERS
123Product label issueFAERS: 2US FAERS
124ProstatismFAERS: 2
Canada Vigilance: 4
10364649
10503165
CTD
Canada Vigilance
US FAERS
125RestlessnessFAERS: 2US FAERS
126Septic ShockFAERS: 2US FAERS
127Sexual DysfunctionFAERS: 2US FAERS
128SomnolenceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
129Spontaneous penile erectionFAERS: 2US FAERS
130Stevens-Johnson SyndromeFAERS: 225811541CTD
SIDER
US FAERS
131StrabismusFAERS: 2US FAERS
132Surgical failureFAERS: 2US FAERS
133ThrombosisFAERS: 2US FAERS
134Urinary tract obstructionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Urine flow decreasedFAERS: 2
Canada Vigilance: 4
Canada Vigilance
US FAERS
136WheezingFAERS: 2US FAERS
137nervous system disorderFAERS: 2SIDER
US FAERS
138treatment failureFAERS: 2US FAERS
139AbasiaFAERS: 1US FAERS
140AbuliaFAERS: 1US FAERS
141Acute kidney injuryFAERS: 1US FAERS
142AgitationFAERS: 1US FAERS
143Altered state of consciousnessFAERS: 1US FAERS
144Anal sphincter atonyFAERS: 1US FAERS
145Anaphylactoid ReactionFAERS: 1US FAERS
146AneurysmFAERS: 1US FAERS
147AngerFAERS: 1US FAERS
148Angina PectorisFAERS: 1US FAERS
149AnosmiaFAERS: 1US FAERS
150AphasiaFAERS: 1US FAERS
151AphoniaFAERS: 1US FAERS
152Bacterial prostatitisFAERS: 1US FAERS
153Bipolar DisorderFAERS: 1US FAERS
154Bladder DiverticulumFAERS: 1US FAERS
155BlepharitisFAERS: 1OFFSIDES
US FAERS
156BlindnessFAERS: 1US FAERS
157Blood PressureFAERS: 1US FAERS
158Cataract operationFAERS: 1OFFSIDES
US FAERS
159Cerebrovascular accidentFAERS: 1US FAERS
160ChillsFAERS: 1SIDER
US FAERS
161CholestasisFAERS: 1US FAERS
162Ciliary zonular dehiscenceFAERS: 1US FAERS
163Coronary Artery DiseaseFAERS: 1US FAERS
164CystitisFAERS: 1US FAERS
165DehydrationFAERS: 1OFFSIDES
US FAERS
166DeliriumFAERS: 1US FAERS
167DementiaFAERS: 1US FAERS
168Depressed Level of ConsciousnessFAERS: 1US FAERS
169Diabetes MellitusFAERS: 1US FAERS
170DisabilityFAERS: 1US FAERS
171DiverticulitisFAERS: 1US FAERS
172Drug administration errorFAERS: 1US FAERS
173Drug dispensing errorFAERS: 1US FAERS
174Drug dose omissionFAERS: 1US FAERS
175Drug effect incompleteFAERS: 1US FAERS
176DysgeusiaFAERS: 1US FAERS
177EmbolismFAERS: 1US FAERS
178EpididymitisFAERS: 1US FAERS
179EpilepsyFAERS: 1US FAERS
180EpistaxisFAERS: 1SIDER
US FAERS
181Erection increasedFAERS: 1US FAERS
182ExophthalmosFAERS: 1US FAERS
183Eye irritationFAERS: 1US FAERS
184Feeling abnormalFAERS: 1SIDER
US FAERS
185Feeling jitteryFAERS: 1US FAERS
186Feelings of worthlessnessFAERS: 1US FAERS
187Gastric ulcerFAERS: 1OFFSIDES
US FAERS
188GastritisFAERS: 1US FAERS
189General physical health deteriorationFAERS: 1US FAERS
190GingivitisFAERS: 1US FAERS
191HydrocephalusFAERS: 1OFFSIDES
US FAERS
192HyperchlorhydriaFAERS: 1US FAERS
193Hyperosmolar stateFAERS: 1US FAERS
194ImmobileFAERS: 1OFFSIDES
US FAERS
195Incorrect route of drug administrationFAERS: 1US FAERS
196Intentional drug misuseFAERS: 1US FAERS
197Interstitial granulomatous dermatitisFAERS: 1US FAERS
198IridoceleFAERS: 1US FAERS
199Left Ventricular HypertrophyFAERS: 1OFFSIDES
US FAERS
200Lenticular injuryFAERS: 1US FAERS
201LichenificationFAERS: 1US FAERS
202Limb injuryFAERS: 1US FAERS
203Male sexual dysfunctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
204Manufacturing materials issueFAERS: 1US FAERS
205Mental impairmentFAERS: 1OFFSIDES
US FAERS
206Mood swingsFAERS: 1US FAERS
207Musculoskeletal PainFAERS: 1US FAERS
208Musculoskeletal discomfortFAERS: 1OFFSIDES
SIDER
US FAERS
209Myasthenia GravisFAERS: 1US FAERS
210NasopharyngitisFAERS: 1SIDER
US FAERS
211NecrosisFAERS: 1US FAERS
212NephrolithiasisFAERS: 1OFFSIDES
US FAERS
213Oropharyngeal discomfortFAERS: 1US FAERS
214PainFAERS: 1OFFSIDES
SIDER
US FAERS
215PancreatitisFAERS: 1US FAERS
216Paraneoplastic pemphigusFAERS: 1US FAERS
217Pharyngeal swellingFAERS: 1US FAERS
218PolyneuropathyFAERS: 1US FAERS
219Positron emission tomogram abnormalFAERS: 1US FAERS
220Posterior capsule ruptureFAERS: 1US FAERS
221PresbyopiaFAERS: 1US FAERS
222Product coating issueFAERS: 1US FAERS
223Product counterfeitFAERS: 1US FAERS
224Product label on wrong productFAERS: 1US FAERS
225Product storage errorFAERS: 1US FAERS
226Product taste abnormalFAERS: 1US FAERS
227Product use complaintFAERS: 1US FAERS
228Prostatic AdenomaFAERS: 1US FAERS
229Prostatic ObstructionFAERS: 1US FAERS
230Pulmonary congestionFAERS: 1US FAERS
231PurpuraFAERS: 1US FAERS
232Quality of life decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
233Rectal tenesmusFAERS: 1US FAERS
234Renal tubular atrophyFAERS: 1US FAERS
235Respiratory tract congestionFAERS: 1US FAERS
236Retinal DetachmentFAERS: 1US FAERS
237RhabdomyolysisFAERS: 1US FAERS
238Similar reaction on previous exposure to drugFAERS: 1US FAERS
239SinusitisFAERS: 1SIDER
US FAERS
240Skin IndurationFAERS: 1OFFSIDES
US FAERS
241Sudden Visual LossFAERS: 1US FAERS
242Sudden deathFAERS: 1US FAERS
243Symptom recurrenceFAERS: 1US FAERS
244TachyarrhythmiaFAERS: 1US FAERS
245TaciturnityFAERS: 1US FAERS
246Therapeutic product effect variableFAERS: 1US FAERS
247Therapy cessationFAERS: 1US FAERS
248Therapy changeFAERS: 1US FAERS
249Tooth LossFAERS: 1US FAERS
250ToothacheFAERS: 1US FAERS
251TremorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
252Urinary strainingFAERS: 1US FAERS
253VasculitisFAERS: 1US FAERS
254VertigoFAERS: 1SIDER
US FAERS
255Wrong technique in drug usage processFAERS: 1US FAERS
256Abdominal strangulated herniaOFFSIDES
257Abdominal wall infectionOFFSIDES
258Abnormal ejaculationSIDER
259AbuseOFFSIDES
260Actinic keratosisOFFSIDES
261Acute Coronary SyndromeOFFSIDES
262Acute bronchitisOFFSIDES
263AlopeciaOFFSIDES
264AlveolitisOFFSIDES
265AlveoloplastyOFFSIDES
266Amaurosis FugaxOFFSIDES
267AmblyopiaSIDER
268AmphetaminesOFFSIDES
269Anorectal operationOFFSIDES
270ApathyOFFSIDES
271AphagiaOFFSIDES
272Application site erythemaOFFSIDES
273Application site excoriationOFFSIDES
274Application site reactionOFFSIDES
275Application site scabOFFSIDES
276Arteriovenous fistula thrombosisOFFSIDES
277ArthritisSIDER
278Aspiration PneumoniaOFFSIDES
279AsthenopiaOFFSIDES
280AtaxiaOFFSIDES
281AtelectasisOFFSIDES
282Atrial tachycardiaOFFSIDES
283Bacterial sepsisOFFSIDES
284BedriddenOFFSIDES
285Blood GlucoseOFFSIDES
286Blood alkaline phosphatase increasedOFFSIDES
287Blood amylase decreasedOFFSIDES
288Blood chloride decreasedOFFSIDES
289Blood glucose decreasedOFFSIDES
290Blood glucose fluctuationOFFSIDES
291Blood immunoglobulin G increasedOFFSIDES
292Blood lactate dehydrogenase increasedOFFSIDES
293Blood magnesium decreasedOFFSIDES
294Blood potassium decreasedOFFSIDES
295Blood sodiumOFFSIDES
296Blood urea increasedOFFSIDES
297Bone lesionOFFSIDES
298Bone painOFFSIDES
299Bone swellingOFFSIDES
300Bone trimmingOFFSIDES
301Brain natriuretic peptide increasedOFFSIDES
302Carnitine decreasedOFFSIDES
303Catheter placementOFFSIDES
304Catheter related infectionOFFSIDES
305Catheter site painOFFSIDES
306CellulitisOFFSIDES
307Chemotherapeutic drug level increasedOFFSIDES
308ClaustrophobiaOFFSIDES
309ClonusOFFSIDES
310Clostridium colitisOFFSIDES
311Common ColdSIDER
312Complex partial seizuresOFFSIDES
313CrystalluriaOFFSIDES
314CystOFFSIDES
315Decreased LibidoOFFSIDES
316DemyelinationOFFSIDES
317Dental PlaqueOFFSIDES
318Dental abscessOFFSIDES
319Dental cariesOFFSIDES
320Denture wearerOFFSIDES
321DermatitisSIDER
322Device breakageOFFSIDES
323Device related infectionOFFSIDES
324DiarrheaOFFSIDES
325Diffuse Large B-Cell LymphomaOFFSIDES
326DiscomfortSIDER
327Disseminated Intravascular CoagulationOFFSIDES
328Disturbance in sexual arousalSIDER
329Dizziness aggravatedSIDER
330Dizzy spellsSIDER
331DrowsinessOFFSIDES
332Drug administered at inappropriate siteOFFSIDES
333Drug screen positiveOFFSIDES
334Dry skinCanada Vigilance: 1Canada Vigilance
OFFSIDES
335Emotional distressOFFSIDES
336Enterococcal infectionOFFSIDES
337Epigastric discomfortCanada Vigilance: 1Canada Vigilance
338Erosive gastritisOFFSIDES
339Erythema MultiformeSIDER
340ExcoriationOFFSIDES
341Femoral pulse decreasedOFFSIDES
342Fluid overloadOFFSIDES
343FormicationOFFSIDES
344Fungus sputum test positiveOFFSIDES
345GamblingOFFSIDES
346Gastrointestinal PainSIDER
347GranulocytosisOFFSIDES
348HemiparesisOFFSIDES
349Heparin-induced thrombocytopeniaOFFSIDES
350HidradenitisOFFSIDES
351HydronephrosisOFFSIDES
352HyperkeratosisOFFSIDES
353HyperreflexiaOFFSIDES
354HypocomplementaemiaOFFSIDES
355HypokinesiaOFFSIDES
356Hypotension orthostatic symptomaticSIDER
357Hypotension, Orthostatic9643668CTD
358Immune reconstitution syndromeOFFSIDES
359ImpatienceOFFSIDES
360InfectionOFFSIDES
SIDER
361InfestationSIDER
362Influenza-like symptomsSIDER
363InfluenzaSIDER
364Infusion site mobility decreasedOFFSIDES
365Intestinal anastomosis complicationOFFSIDES
366Intestinal infarctionOFFSIDES
367Intraoperative floppy iris syndromeSIDER
368Iris Diseases18299077CTD
369Joint InstabilityOFFSIDES
370Joint Range of Motion DecreasedOFFSIDES
371Joint injuryOFFSIDES
372Joint stiffnessOFFSIDES
373Kidney FailureOFFSIDES
374Large intestine perforationOFFSIDES
375LethargyOFFSIDES
376Leukopenia neonatalOFFSIDES
377LightheadednessSIDER
378Limb discomfortCanada Vigilance: 1Canada Vigilance
379Lung consolidationOFFSIDES
380Male Urogenital Diseases15705083
16842616
CTD
381MalnutritionSIDER
382Markedly reduced dietary intakeOFFSIDES
383Medication residueOFFSIDES
384Mental status changesOFFSIDES
385Metastatic NeoplasmOFFSIDES
386Mouth Diseases19837435CTD
387Muscle WeaknessOFFSIDES
388Muscle strainOFFSIDES
389Muscle tightnessOFFSIDES
390Neck PainSIDER
391Nephrogenic Fibrosing DermopathyOFFSIDES
392Neutropenic infectionOFFSIDES
393NoduleOFFSIDES
394Occult blood positiveOFFSIDES
395OliguriaOFFSIDES
396OnychoclasisOFFSIDES
397OrchitisOFFSIDES
398Oxygen saturation abnormalOFFSIDES
399Paranasal sinus hypersecretionOFFSIDES
400Pelvic massOFFSIDES
401PeriodontitisOFFSIDES
402PharyngitisSIDER
403Postoperative infectionOFFSIDES
404Product complaintCanada Vigilance: 6Canada Vigilance
405Product dosage form issueCanada Vigilance: 1Canada Vigilance
406Product substitutionCanada Vigilance: 1Canada Vigilance
407Productive CoughOFFSIDES
408Prostatic Diseases20981257CTD
409Prostatic Hyperplasia

View details

CTD
410Reaction gastrointestinalSIDER
411Rectal dischargeOFFSIDES
412Respiratory FailureOFFSIDES
413RhinorrheaOFFSIDES
414Seizures17054698CTD
415Semen volume decreasedCanada Vigilance: 1Canada Vigilance
OFFSIDES
416Senile dementiaOFFSIDES
417Serratia sepsisOFFSIDES
418ShockSIDER
419Sick Sinus SyndromeOFFSIDES
420Sinus bradycardiaOFFSIDES
421Skin hypertrophyOFFSIDES
422Skin lacerationCanada Vigilance: 1Canada Vigilance
OFFSIDES
423Skin tightnessOFFSIDES
424Sputum retentionOFFSIDES
425Subcutaneous noduleOFFSIDES
426Suture related complicationOFFSIDES
427SweatingSIDER
428Therapeutic product effect decreasedCanada Vigilance: 3Canada Vigilance
429Therapeutic response changedCanada Vigilance: 7Canada Vigilance
430Tooth ExtractionOFFSIDES
431Transfusion ReactionOFFSIDES
432Unresponsive to stimuliOFFSIDES
433Urinary tract infection pseudomonalOFFSIDES
434Urologic Diseases20126606CTD
435Vitamin A DeficiencyOFFSIDES
436Weight GainOFFSIDES
437Wound dehiscenceOFFSIDES
438prostatitisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.